Targeted Delivery of Raloxifene via RGD-functionalized Chitosan Nanoparticle Selectively Attenuates Breast Tumor Growth
Breast cancer is one of the most frequently diagnosed cancers among women around the globe. It is usually addressed through chemotherapy, radiation, and surgical interventions—methods that are often hindered by toxicity, non-specificity, and resistance to drugs. This study, presented at ICRAN 2025, introduces a nanotechnology-based strategy that uses RGD peptide-conjugated chitosan nanoparticles (
